Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Naredi

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1994
Hepatic artery occlusion and energy charge in rat liver tumourP Lindnér, B Biber, B Gustavsson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 12, 2003
A comparison between hepatic artery ligation and portal 5-Fu infusion versus 5-Fu intra arterial infusion for colorectal liver metastasesP Naredi, M Oman, P-J Blind, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 1, 1997
Histamine in cancer immunotherapyK Hellstrand, S Hermodsson, M Brune, et al.
International Journal of Oncology|April 30, 2011
Synergy between cisplatin and an inhibitor of S-adenosylmethionine dependent transmethylation in human ovarian adenocarcinoma cellsS Aebi, R Christen, P Naredi, et al.
Anticancer Research|May 1, 1994
Biochemical modulation of intraperitoneal fluorouracil by allopurinol-the effect on an experimental adenocarcinoma in the liverP Lindnér, G Carlsson, B Gustavsson, et al.
Surgical Oncology|January 1, 1993
Regional lymphatic drug exposure following intraperitoneal administration of 5-fluorouracil, carboplatin, and etoposideP Lindnér, D D Heath, D R Shalinsky, et al.
Cancer Investigation|May 16, 2000
Histamine: a novel approach to cancer immunotherapyK Hellstrand, M Brune, P Naredi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 22, 2007
Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-{alpha}2b and histamine dihydrochloride versus dacarbazine in patients with stage IV melanomaM Middleton, A Hauschild, D Thomson, et al.
Medical Oncology (Northwood, London, England)|December 15, 2000
Alleviating oxidative stress in cancer immunotherapy: a role for histamine?K Hellstrand, M Brune, C Dahlgren, et al.
BJS Open|July 26, 2021
Patterns and resectability of colorectal cancer recurrences: outcome study within the COLOFOL trialP Hansdotter, P Scherman, S H Petersen, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1994
Hepatic artery occlusion and energy charge in rat liver tumourP Lindnér, B Biber, B Gustavsson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 12, 2003
A comparison between hepatic artery ligation and portal 5-Fu infusion versus 5-Fu intra arterial infusion for colorectal liver metastasesP Naredi, M Oman, P-J Blind, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 1, 1997
Histamine in cancer immunotherapyK Hellstrand, S Hermodsson, M Brune, et al.
International Journal of Oncology|April 30, 2011
Synergy between cisplatin and an inhibitor of S-adenosylmethionine dependent transmethylation in human ovarian adenocarcinoma cellsS Aebi, R Christen, P Naredi, et al.
Anticancer Research|May 1, 1994
Biochemical modulation of intraperitoneal fluorouracil by allopurinol-the effect on an experimental adenocarcinoma in the liverP Lindnér, G Carlsson, B Gustavsson, et al.
Surgical Oncology|January 1, 1993
Regional lymphatic drug exposure following intraperitoneal administration of 5-fluorouracil, carboplatin, and etoposideP Lindnér, D D Heath, D R Shalinsky, et al.
Cancer Investigation|May 16, 2000
Histamine: a novel approach to cancer immunotherapyK Hellstrand, M Brune, P Naredi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 22, 2007
Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-{alpha}2b and histamine dihydrochloride versus dacarbazine in patients with stage IV melanomaM Middleton, A Hauschild, D Thomson, et al.
Medical Oncology (Northwood, London, England)|December 15, 2000
Alleviating oxidative stress in cancer immunotherapy: a role for histamine?K Hellstrand, M Brune, C Dahlgren, et al.
BJS Open|July 26, 2021
Patterns and resectability of colorectal cancer recurrences: outcome study within the COLOFOL trialP Hansdotter, P Scherman, S H Petersen, et al.
Pageof 6